Danaher Corporation $DHR Shares Acquired by ING Groep NV

ING Groep NV lifted its position in Danaher Corporation (NYSE:DHR) by 143.7% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 350,986 shares of the conglomerate’s stock after acquiring an additional 206,976 shares during the period. ING Groep NV’s holdings in Danaher were worth $69,586,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in DHR. WFA of San Diego LLC purchased a new stake in Danaher during the 2nd quarter valued at about $26,000. Howard Hughes Medical Institute acquired a new stake in shares of Danaher during the second quarter worth about $27,000. TruNorth Capital Management LLC purchased a new stake in Danaher in the third quarter valued at approximately $28,000. Tripletail Wealth Management LLC acquired a new position in Danaher in the 3rd quarter worth approximately $31,000. Finally, Heartwood Wealth Advisors LLC purchased a new position in Danaher during the 3rd quarter worth approximately $37,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Trading Up 1.4%

DHR stock opened at $219.66 on Wednesday. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $242.80. The company has a quick ratio of 1.51, a current ratio of 1.87 and a debt-to-equity ratio of 0.35. The firm has a market cap of $155.16 billion, a P/E ratio of 43.58, a PEG ratio of 2.93 and a beta of 0.91. The company’s 50-day simple moving average is $229.33 and its 200-day simple moving average is $215.37.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share for the quarter, beating the consensus estimate of $2.14 by $0.09. The firm had revenue of $6.84 billion during the quarter, compared to analyst estimates of $6.79 billion. Danaher had a return on equity of 10.81% and a net margin of 14.71%.Danaher’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.14 EPS. As a group, equities analysts forecast that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, January 30th. Stockholders of record on Friday, December 26th were paid a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. The ex-dividend date of this dividend was Friday, December 26th. Danaher’s dividend payout ratio is presently 25.40%.

Wall Street Analyst Weigh In

Several analysts have recently commented on the stock. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Danaher in a report on Thursday, January 29th. Barclays upped their price target on shares of Danaher from $225.00 to $250.00 and gave the company an “overweight” rating in a report on Wednesday, October 22nd. Evercore reaffirmed an “outperform” rating and set a $254.00 price target on shares of Danaher in a research report on Wednesday, January 28th. JPMorgan Chase & Co. boosted their price objective on Danaher from $270.00 to $275.00 and gave the company an “overweight” rating in a report on Thursday, January 29th. Finally, Leerink Partners raised their target price on Danaher from $260.00 to $270.00 and gave the stock an “outperform” rating in a report on Friday, January 16th. Twenty analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $253.86.

Insider Activity

In other news, Director Teri List sold 3,298 shares of the stock in a transaction that occurred on Tuesday, November 18th. The stock was sold at an average price of $226.50, for a total transaction of $746,997.00. Following the transaction, the director owned 20,762 shares in the company, valued at $4,702,593. This trade represents a 13.71% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 11.20% of the stock is owned by company insiders.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.